Search companies

Live

Tuesday, 17 November 2026 · 580 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

MVP Reports FY26 Growth, Sets Out Penthrox Expansion Priorities

MVP: $0.440 +0.00% · MC: $50M

Medical Developments International reported FY26 revenue growth of 9% to $43 million, a small EBIT profit and free cash flow that improved by $6 million, while Penthrox volumes rose across regions. At its AGM, the company said it expects continued progress in the year ahead through efforts to deepen Penthrox use and expand into new geographies and segments; shareholders approved its new rights plan.

Source announcements: 2026-11-12 11:46 to 2026-11-12 17:19 Sydney time
Story updated 2026-11-12 17:23 Sydney time
Sources2026 Annual General Meeting Chair and CEO Address2026 Annual General Meeting PresentationResults of 2026 Annual General Meeting2026 Annual General Meeting Recording
Comments